Biofrontera AG buy krebskrebs
Start price
16.08.21
/
50%
€2.49
Target price
16.08.22
€4.00
Performance (%)
-50.80%
End price
17.08.22
€1.23
Summary
This prediction ended on 17.08.22 with a price of €1.23. The BUY prediction by krebskrebs for Biofrontera AG performed very badly with a performance of -50.80%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biofrontera AG | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by krebskrebs for this prediction
In the thread Biofrontera AG diskutieren
In the thread Trading Biofrontera AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten